This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Add CRM Stock to Your Portfolio Ahead of Q4 Earnings?
by Anirudha Bhagat
Salesforce's Q4 performance is likely to reflect the benefits of the growing adoption of generative AI-enabled solutions and continued cloud migration.
Oracle (ORCL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the most recent trading session, Oracle (ORCL) closed at $181.52, indicating a +0.96% shift from the previous trading day.
Cadence Design Systems (CDNS) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cadence (CDNS) delivered earnings and revenue surprises of 3.30% and 0.60%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Oracle (ORCL) Gained But Lagged the Market Today
by Zacks Equity Research
In the closing of the recent trading day, Oracle (ORCL) stood at $173.86, denoting a +0.95% change from the preceding trading day.
Is Oracle (ORCL) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Oracle (ORCL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Oracle (ORCL) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
In the most recent trading session, Oracle (ORCL) closed at $172.35, indicating a +0.4% shift from the previous trading day.
Here is What to Know Beyond Why Oracle Corporation (ORCL) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Oracle (ORCL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should You Invest in the iShares Expanded Tech-Software Sector ETF (IGV)?
by Zacks Equity Research
Sector ETF report for IGV
Microsoft Cloud Hits Capacity Wall: Buy, Sell or Hold MSFT Stock?
by Vasundhara Sawalka
MSFT's cloud growth hits the capacity wall despite strong AI momentum. Investors can hold existing positions or wait for a better entry point.
Oracle (ORCL) Stock Moves -0.19%: What You Should Know
by Zacks Equity Research
The latest trading day saw Oracle (ORCL) settling at $170.06, representing a -0.19% change from its previous close.
Microsoft Q2 Earnings & Revenues Beat on Surging AI Business
by Zacks Equity Research
MSFT's second-quarter fiscal 2025 results reflect strength in AI business and Copilot adoption amid decelerating growth in its Azure cloud infrastructure unit.
Stock Market News for Jan 29, 2025
by Zacks Equity Research
U.S. stocks ended higher on Tuesday, with the S&P and the Nasdaq recovering most of their losses from the previous session that saw a Wall Street bloodbath, triggered by the sudden emergence of Chinese AI startup DeepSeek.
The Zacks Analyst Blog Highlights First Solar, NextEra Energy, Enphase Energy and Oracle
by Zacks Equity Research
First Solar, NextEra Energy, Enphase Energy and Oracle are part of the Zacks top Analyst Blog.
A Massive $500 Billion Bet on US Tech Future: FSLR, NEE, ENPH to Gain?
by Nilanjan Banerjee
A new alliance plans to invest up to $500 billion to build AI infrastructure, opening up opportunities for First Solar, NextEra & Enphase.
5 Stocks That Powered S&P 500 ETF in Trump's First Week
by Sweta Killa
The S&P 500 logs the best first week of a presidential term in four decades. Here are five stocks in the ETF that led the gains.
Oracle (ORCL) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
Oracle (ORCL) closed the most recent trading day at $183.60, moving -1.54% from the previous trading session.
Market Update: S&P 500 Hits New High, AI Spending Surges
by Andrew Rocco
The current market outlook leans bullish, especially over the long-term. Stock Strategist Andrew Rocco breaks it all down in today's commentary.
The Zacks Analyst Blog Tesla, UnitedHealth Group, Oracle and Earth Science Tech
by Zacks Equity Research
Tesla, UnitedHealth Group, Oracle and Earth Science Tech are included in this Analyst Blog.
The Zacks Analyst Blog Broadcom, NVIDIA, Amazon.com, Arista Networks and Oracle
by Zacks Equity Research
Broadcom, NVIDIA, Amazon.com, Arista Networks and Oracle are included in this Analyst Blog.
Top Research Reports for Tesla, UnitedHealth & Oracle
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), UnitedHealth Group Incorporated (UNH) and Oracle Corporation (ORCL), as well as a micro-cap stock Earth Science Tech, Inc. (ETST).
S&P on Track to Hit New Record High on AI Optimism: 4 Stocks to Buy
by Ritujay Ghosh
Tech stocks like AVGO, NVDA, AMZN and ANET are poised to gain from the ongoing rally driven by AI optimism.
IBM Stock Before Q4 Earnings: A Smart Buy or Risky Investment?
by Supriyo Bose
With declining earnings estimates, IBM is witnessing a negative investor perception and it might be prudent to avoid the stock at the moment.
Is Trending Stock Oracle Corporation (ORCL) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Oracle (ORCL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Trump Unveils Stargate AI Infrastructure Project: ETFs in Focus
by Sanghamitra Saha
On Tuesday, Trump announced a $500 billion AI infrastructure initiative, spearheading a new company called Stargate.
Stock Market News for Jan 23, 2025
by Zacks Equity Research
U.S. stocks ended higher on Wednesday after President Trump announced a $500 billion investment in AI infrastructure.